• 09:47

In the exercise period for the warrants in Immunicum’s option program for senior executives that ended March 31, 2016, 260,000 warrants were exercised.
The options have been exercised by issuing 130 000 shares with a par value of SEK 0.05 per share.
In connection with this exercise, Immunicum added SEK 3.12 million from the option holders which was entirely recorded in equity. The Company’s share capital amounts after exercise to SEK 1.008 million and the number of shares amounts to 20,160,000.